(Q53120030)

11 May 2018

title

Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge. (English)

1 reference

11 May 2018

author

Jonathan M Payne

2

1 reference

11 May 2018

Kathryn North

5

1 reference

11 May 2018

Nigel F Clarke

4

object named as

Nigel F Clarke

1 reference

11 May 2018

author name string

Emily C Oates

1

1 reference

11 May 2018

Sheryl L Foster

3

1 reference

11 May 2018

language of work or name

English

0 references

publication date

20 February 2013

1 reference

11 May 2018

American Journal of Medical Genetics

published in

1 reference

11 May 2018

volume

161A

1 reference

11 May 2018

issue

4

1 reference

11 May 2018

page(s)

659-666

1 reference

11 May 2018

Social skills of children with neurofibromatosis type 1.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Neurological complications of neurofibromatosis type 1 in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Intellectual impairment in neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Clinical and genetic aspects of neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Neurofibromin (Nf1) is required for skeletal muscle development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Decreased bone mineral density in patients with neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Cognitive deficits in neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Do NF1 gene deletions result in a characteristic phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

MRI findings in children with neurofibromatosis type 1: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

Neurofibromatosis type 1 and associated malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35840

21 January 2018

Identifiers

DOI

10.1002/AJMG.A.35840

1 reference

11 May 2018

1 reference

11 May 2018